Right ventricle-sparing heart transplantation effective against iatrogenic pulmonary hypertension

Journal of Heart and Lung Transplantation

Volumn 23, Issue 2, 2004, Pages 236-241

  Lovoulos, Constantinos ^a   Tittle, Shawn ^a   Goldstein, Lee ^a   Austin, David J ^a   Singh, Simran ^a   Rocco, Edward ^a   Keane, James ^a   Tang, Ping ^a   Kopf, Gary S ^a   Elefteriades, John A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCROTALINE PYRROLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; FEASIBILITY STUDY; HEART CONTRACTION; HEART DILATATION; HEART RIGHT ATRIUM PRESSURE; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE HYPERTROPHY; HEART TRANSPLANTATION; HISTOPATHOLOGY; IATROGENIC DISEASE; IATROGENIC PULMONARY HYPERTENSION; LUNG VASCULAR RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SURGICAL TECHNIQUE; SYSTOLIC BLOOD PRESSURE;

EID: 10744219682     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(03)00110-4     Document Type: Article

References (7)

1. Levett D., Karp R. Heart transplantation. Surg Clin N Am. 65:1985;613-635.
2. Costard-Jackle A., Fowler M. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high-risk group . J Am Coll Cardiol. 19:1992;48-54.
3. Elefteriades J., Lovoulos C., Tellides G., et al. Right ventricle-sparing heart transplant promising new technique for recipients with pulmonary hypertension . Ann Thorac Surg. 69:2000;1858-1863.
4. Chen E., Bittner H., Tull F., et al. An adult canine model of chronic pulmonary hypertension for cardiopulmonary transplantation. J Heart Lung Transplant. 16:1997;538-547.
5. Mattocks A.R., Jukes R., Brown J. Simple procedures for preparing putative toxic metabolites of pyrrolizidine alkaloids. Toxicon. 27:1989;561-567.
6. Cooper D., Novitsky D., Beccera E., et al. Are there indications for heterotopic heart transplantation? A 2- to 11-year follow-up of 49 consecutive patients. J Thorac Cardiovasc Surg. 34:1986;300-304.
7. Nakatani T., Frazier O., Lammermeier D., et al. Heterotopic heart transplantation a reliable option for selected high-risk patients . J Heart Transplant. 8:1989;40-47.